RAMM Pharma Corp. Awaits Key Litigation Verdict
RAMM Pharma Corp: MDA EN
RAMM Pharma Corp: AUDITED ANNUAL FINANCIAL STATEMENTS EN
RAMM Pharma Corp. Announced Corporate Update; Looking At Legal Options Around Private Placement; Rose 28% on Friday
RAMM Pharma Corp. Announces Corporate Update.
RAMM Pharma Corp: INTERIM MDA EN
RAMM Pharma Corp: INTERIM FINANCIAL STATEMENTSREPORT EN
RAMM Pharma Seeking Advice After CSE Required Shareholder Approval For Private Placement
RAMM Pharma Corp. Announces Clarification of Its Corporate Update of September 12th
RAMM Pharma Corp. Announces Corporate Update
RAMM Pharma Corp. Announces Non-Brokered Private Placement and Intention to Commence Normal Course Issuer Bid
RAMM Pharma Corp: ON FORM 13-502F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
RAMM Pharma Corp: AUDITED ANNUAL FINANCIAL STATEMENTS - ENGLISH
RAMM Pharma Corp: AB FORM 13-501F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
RAMM Pharma Corp. Announces Appointment of Jose Roldan as Interim CFO >RAMM.CN.L
Press Release: RAMM Pharma Corp. Announces Appointment of New Interim-Chief Financial Officer
RAMM Pharma Corp. Acquires Leading European Hemp Manufacturer HemPoland >RAMM.L
RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid
RAMM Pharma Corp: MD&A - ENGLISH
RAMM Pharma Corp: INTERIM FINANCIAL STATEMENTS/REPORT - ENGLISH